The 2025 targets include achieving around €62 billion in revenues, falling costs in absolute terms, a stable cost of risk, ...

The shareholders of Orrön Energy AB (publ), 556610-8055 (“Orrön Energy” or the “Company”), are hereby given notice of the ...

Getting prior authorization for medications can be a struggle in allergy and asthma care, but creating templates and paying ...

KaliVir Immunotherapeutics, Inc., a clinical-stage biotechnology company developing cutting-edge, multi-mechanistic oncolytic immunotherapy programs, today announced the upcoming presentation of a ...

today announced that an abstract highlighting data supporting the immune component of amezalpat’s purported mechanism of action has been accepted for poster presentation at the 2025 American ...

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Zurich, 17 March 2025 – UBS has published its Annual Report, presenting fully audited results for the year ...

The Securities and Exchange Commission (SEC) released the schedule of filing of corporations’ annual financial statements (AFS ... duly registered companies for repeated failure to submit reports. We ...